Hollandbio Seeks Feedback for Biotech Funding Boost
Amsterdam, Wednesday, 22 October 2025.
Hollandbio invites input on the PPSi funding scheme to enhance biotech innovation. The initiative aims to bridge public-private collaboration, tackling funding challenges and spurring growth in the Dutch biotech sector.
Understanding the PPSi Funding Scheme
The Publiek-Private Samenwerkings-innovatieregeling (PPSi) is a critical funding mechanism designed to foster collaborations between public and private sectors in the biotechnology field. The scheme is particularly significant for biotech entrepreneurs in the Netherlands, where securing financial backing for innovative projects remains a top priority. By offering project financing to partnerships between businesses and research institutions, the PPSi aims to accelerate research and development, ultimately leading to impactful innovations [1].
The Role of Hollandbio in Biotech Innovation
Hollandbio, a key player in the Dutch biotechnology landscape, has taken an active role in advocating for a more effective PPSi scheme. The organization emphasizes the need for a funding framework that places businesses at the forefront, ensuring that Dutch companies with research and development capabilities can spearhead projects in collaboration with local knowledge institutions. Hollandbio’s call for input is part of a broader effort to refine the PPSi in alignment with the National Technology Strategy, thereby enhancing its appeal to private entities [1].
Proposed Enhancements and Benefits
The proposed enhancements to the PPSi scheme include increasing the maximum subsidy amount to €5 million per project, which is considered substantial enough to support significant investments in biotech ventures. Additionally, Hollandbio advocates for user-friendly terms that do not hinder innovation with restrictive publication requirements or intellectual property constraints. These improvements aim to make the PPSi more accessible to startups and scale-ups, particularly those classified as Enterprises in Difficulty, thereby nurturing a robust innovation ecosystem [1].
Impact on the Dutch Biotech Sector
The revision of the PPSi scheme is poised to have a transformative impact on the Dutch biotech sector by fostering a more conducive environment for innovation. By easing funding barriers and facilitating partnerships between academia and industry, the initiative is expected to accelerate the transition of scientific research from laboratories to market-ready solutions. This aligns with the broader goal of positioning the Netherlands as a leader in biotech innovation, capable of delivering cutting-edge advancements in medicine, food, healthtech, and agritech [1].